Crossmark

Metformin potentiates DSF/Cu-loaded pluronic nanoparticles to improve therapeutic efficacy in triple-negative breast cancer

Published Online: 2026-02-23

Authors

Pourbakhsh, Mehdi

Doustmihan, Abolfazl

Jabraili, Masoud

Fathi, Marziyeh

Jahanban Esfahlan, Rana
License Information

Text and Data Mining valid from 2026-02-23

Version of Record valid from 2026-03-27
More Information

Article History

Received: 29 October 2025

Accepted: 9 February 2026

First Online: 23 February 2026

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current